Back to Search Start Over

Computational models can predict response to HIV therapy without a genotype and may reduce treatment failure in different resource-limited settings.

Authors :
Revell AD
Wang D
Wood R
Morrow C
Tempelman H
Hamers RL
Alvarez-Uria G
Streinu-Cercel A
Ene L
Wensing AM
DeWolf F
Nelson M
Montaner JS
Lane HC
Larder BA
Source :
The Journal of antimicrobial chemotherapy [J Antimicrob Chemother] 2013 Jun; Vol. 68 (6), pp. 1406-14. Date of Electronic Publication: 2013 Mar 13.
Publication Year :
2013

Abstract

Objectives: Genotypic HIV drug-resistance testing is typically 60%-65% predictive of response to combination antiretroviral therapy (ART) and is valuable for guiding treatment changes. Genotyping is unavailable in many resource-limited settings (RLSs). We aimed to develop models that can predict response to ART without a genotype and evaluated their potential as a treatment support tool in RLSs.<br />Methods: Random forest models were trained to predict the probability of response to ART (ā‰¤400 copies HIV RNA/mL) using the following data from 14ā€Š891 treatment change episodes (TCEs) after virological failure, from well-resourced countries: viral load and CD4 count prior to treatment change, treatment history, drugs in the new regimen, time to follow-up and follow-up viral load. Models were assessed by cross-validation during development, with an independent set of 800 cases from well-resourced countries, plus 231 cases from Southern Africa, 206 from India and 375 from Romania. The area under the receiver operating characteristic curve (AUC) was the main outcome measure.<br />Results: The models achieved an AUC of 0.74-0.81 during cross-validation and 0.76-0.77 with the 800 test TCEs. They achieved AUCs of 0.58-0.65 (Southern Africa), 0.63 (India) and 0.70 (Romania). Models were more accurate for data from the well-resourced countries than for cases from Southern Africa and India (Pā€Š<ā€Š0.001), but not Romania. The models identified alternative, available drug regimens predicted to result in virological response for 94% of virological failures in Southern Africa, 99% of those in India and 93% of those in Romania.<br />Conclusions: We developed computational models that predict virological response to ART without a genotype with comparable accuracy to genotyping with rule-based interpretation. These models have the potential to help optimize antiretroviral therapy for patients in RLSs where genotyping is not generally available.

Details

Language :
English
ISSN :
1460-2091
Volume :
68
Issue :
6
Database :
MEDLINE
Journal :
The Journal of antimicrobial chemotherapy
Publication Type :
Academic Journal
Accession number :
23485767
Full Text :
https://doi.org/10.1093/jac/dkt041